FilingReader Intelligence

WuXi AppTec subsidiary liquidates private equity investment

September 26, 2025 at 05:27 PM UTCBy FilingReader AI

Wuxi AppTec Co., Ltd. announced that its wholly-owned subsidiary, Wuxi AppTec Phase I Investment Enterprise (Limited Partnership), will liquidate its investment in Huaping Big Health Industry Investment (Wuxi Yixing) Partnership Enterprise (Limited Partnership). This decision was made by all partners of the Investment Fund as a result of changes in market conditions.

On October 20, 2023, Wuxi AppTec Phase I and Shanghai Huaping Private Equity Fund Management Co., Ltd., along with other partners, signed a limited partnership agreement. This agreement committed Wuxi AppTec Phase I to subscribe for up to RMB 60,000 million in Investment Fund units. As of the disclosure date of this announcement, Wuxi AppTec Phase I had contributed RMB 24,000 million to the Investment Fund.

The Investment Fund currently has no completed investment projects. Wuxi AppTec Phase I anticipates recovering its principal investment of RMB 24,000 million, along with related interest income. The company stated that the termination of this investment will not have a material impact on its financial or operational activities and will not harm the interests of the company or its shareholders.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:603259Shanghai Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when WuXi AppTec publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →